Excessive SMC growth within the vascular wall after trauma -proliferation -apoptosis -migration - accelerated matrix deposition major cause of failure.

Slides:



Advertisements
Similar presentations
Adult Stem Cell Interaction With Engineered Scaffolds
Advertisements

Pathologic Intimal Hyperplasia as a Response to Vascular Injury and Reconstruction.
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
Frank Baaijens et al. Laboratory for Tissue Biomechanics and Tissue Engineering, Department of Biomedical Engineering, TU/e Simon Hoerstrup et al. Laboratory.
HELICAL STE NTS C.G.Caro Department of Bioengineering Imperial College.
Improved Vascular Remodeling and Endothelial Function in Transglutaminase 2 Knock-Out Mice Infused with Angiotensin II L.Sada1,C.Savoia1,M.Briani1,E Arrabito1,S.Michelini1,L.Pucci1,
Cardiovascular Tissue Engineering Devin Nelson July 2010 Department of Bioengineering, University of Pittsburgh McGowan Institute for Regenerative Medicine.
Experimental Non-Inferiority Trial of Synthetic Small-calibre Biodegradable vs. Stable Vascular Grafts Departments of 1 Cardiovascular Surgery, 3 Pathology.
LECTURE 6BIOMATERIALS1 BIOSENSORS A biosensor is an analytical device which converts a biological response into an electrical signal. The term 'biosensor'
Tissue Repair Dr. Raid Jastania. What is Repair? When does regeneration occur? When does fibrosis occur? What are the consequences of fibrosis?
Aging of the Cardiovascular System (continued)
ATHEROSCLEROSIS By Joshua Bower Easter Revision 2014
Kenneth M. Yamada & Edna Cukierman. Introduction 2D cell cultures Studies in standard cell culture have produced many important conceptual advances Nevertheless,
TisXell Regeneration System. Company Background …(1) QuinXell Technologies Pte Ltd was founded in 2011 QuinXell is the latest addition to Quintech Life.
Tissue Engineering Goal: Regenerate or repair tissues Challenge: Understand how tissues are built in-vivo  i.e. what instructions do cells need to organize.
Biomaterials Science Part II: Materials in Medicine Synthetic Vascular Grafts March 6, 2010 assignment reading: Brett C. Isenberg, Chrysanthi Williams.
SHOCK Background concept Shock is a severe pathological process under the effect of various types of etiological factors, characterized by acute circulatory.
The Science Behind Taxus Advanced Angioplasty 2004 Christian Vander Velde, Boston Scientific Europe, Marketing.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Supermacroprous chitosan–agarose–gelatin cryogels: in vitro characterization and in vivo assessment for cartilage tissue engineering by Sumrita Bhat, Anuj.
GAS EXCHANGE (Lecture 5). The ultimate aim of breathing is to provide a continuous supply of fresh O2 by the blood and to constantly remove CO2 from the.
Cardiovascular Tissue Engineering Priya Ramaswami July 26, 2006 Department of Bioengineering, University of Pittsburgh McGowan Institute for Regenerative.
Cardiovascular Block Coronary Circulation
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Project #2: Hemodynamic Evaluation of Arteriovenous Fistula
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
Molecular methods of cell culture III. Apoptosis  Programmed cell death  A physiological mechanism to eliminate excess, damaged or dangerous cells from.
Remodelling Ability of living tissue to adapt to its environment by changing its shape and structure Modifies mechanical properties Driven by tendency.
 Prof. A. M. Vollmar  PD Dr. V. M. Dirsch  Thomas Roos  Nancy Lopez WP 5: Cardiovascular diseases 5.1: The Interaction of garlic with mediators of.
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Wound Healing Dr. Raid Jastania.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Overview of advanced glycation end-products (AGEs) Part 2
R1 정수웅.  Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause that occurs.
Arginase I enhances vascular smooth muscle cell proliferation by increasing intracellular polyamine production (A and B) Arginase I enhances cell proliferation.
Venous Thromboembolism-1
Is atherosclerosis a metabolic disease?
Design of a Biodegradable Vascular Construct
Mechanisms of production of atheroma
Fatima Obeidat. MD Lecture I
Fundamentals of Multiscale Fabrication
Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide  Kathleen G.
Supervised by: Dr. Paul French, Dr. Mark Murphy, and Dr. Martin Sharp
Xue Ma, MD, Jeffrey D. Pearce, MD, David B. Wilson, MD, William P
S. S. Pullamsetti, R. Savai, W. Janssen, B. K. Dahal, W. Seeger, F
Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats  Bassam Alkhatib, MD, Caroline Freguin-Bouilland,
Cardiovascular Tissue Engineering
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Tunica Externa Outermost layer of the blood vessel
Blood Vessels D. Matesic
Fig 6.1 Drug released by diffusion
Figure 4 TNFSF inflammatory activities in tissue cells
Section 4: Plaque dynamics and stenosis
Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase– and protein kinase C–dependent manner  Angela G.
Mark F. Fillinger, MD, Susan E. O'Connor, MD, Robert J
Lino Ferreira, Jeffrey M. Karp, Luis Nobre, Robert Langer 
Yasuko Iwakiri, Vijay Shah, Don C. Rockey  Journal of Hepatology 
Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins  Xavier Berard, MD, PhD, Sébastien Déglise, MD, Florian Alonso, PhD,
Vein graft failure Journal of Vascular Surgery
Gabriele Di Luozzo, MD, Jaya Bhargava, PhD, Richard J. Powell, MD 
Margus Annuk, Mihkel Zilmer, Bengt Fellström
The molecular mechanisms of hemodialysis vascular access failure
Correction Journal of Vascular Surgery
Process and mechanisms of blood vessel formation.
Atherosclerosis Dr:HAMED ALGHAMDI.
Early Fistula Failure: Back to Basics
Endothelial regulation: Understanding RAS
Claudia Loebel, Jason A. Burdick  Cell Stem Cell 
Effects of somatostatin, somatostatin analogs, and endothelial cell somatostatin gene transfer on smooth muscle cell proliferation in vitro  Rajabrata.
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Presentation transcript:

excessive SMC growth within the vascular wall after trauma -proliferation -apoptosis -migration - accelerated matrix deposition major cause of failure of endovascular and vascular reconstructions so far very difficult to treat Intimal hyperplasia

Trauma Platelet aggregation Hemodynamic factors Humoral factors altered SMC-EC interaction Intimal hyperplasia affected by multiple factors

Endothelially derived -vasodilating agents - relaxation agents vasoconstrictors Cell to cell interaction? Intimal hyperplasia altered SMC-EC interaction

Intimal hyperplasia in stent -restenosis-

Intimal hyperplasia -restenosis-

Intimal hyperplasia -restenosis management challenging

intimal hyperplasia and EC / SMC interaction are difficult to study in in vivo studies we cannot separate hemodynamic, intercellular and humoral effects In in vitro studies cannot reproduce clinical effects of EC/SMC interaction

EC / SMC interaction is difficult to study In in vivo stable conditions intact confluent ECs control intimal hyperplasia by: -enhanced production of NO -decreased production of endothelin - production of anti inflammatory agents such as heparan sulfate regenerating ECs may have an opposite effect

in vitro conventional cocultures Endothelial cells Enhance SMC migration promote SMC proliferation encourage unhealthy vascular remodeling Data from conventional cocultures do not allow direct translation of the results Powell, Cronewett, et al

There is need for in vitro vasculature models Hemodynamic factors: shear stress, pressure Matrix Physiologic features of the vascular wall -compliance, elasticity

Coculture model Rat aortic SMCs in wells Rat aortic ECs in inserts inserts transferred into wells at 24 hrs semipermeable (3.0  m pore) membrane no cell contact EC SMCs

Pressure apparatus Custom-made chamber 130mm Hg monitored with manometer 95% room air and 5%CO C temperature- humidity daily media pH measurements

Coculture model EC SMCs Extracellular pressure mmHg

Four pressure-culture conditions SMCs EC SMCs EC SMCs 130mmHg

Effect of pressure on EC/SMC coculture C-myc dependent Late entry to S-Phase Vouyouka et al JSR 2003

SMCs stained with TUNEL SMC/0 SMC/0-P SMC/EC-P SMC/EC

Pressure and coculture enhances SMC apoptosis Vouyouka et al Surgery 2004 Topisomerase IIa Fas- Fas Ligand

Effect of pressure and coculture on SMC Topoisomerase II  * SMC/0 SMC/EC SMC/0-P SMC/EC-P Topo II  Actin *

Effect of pressure and coculture on SMC Topoisomerase II  * SMC/0 SMC/EC SMC/0-P SMC/EC-P Topo II  Actin *

* Pressure and coculture increases iNOS

Extracellular pressure is a major regulator of EC/SMC interaction Regulates cocultured SMC growth by enhancing apoptosis and inhibiting SMC proliferation. Mediates these effects mostly through endothelial paracrine function that involves NO and endothelin mediation

Electrospinning fibers with different chemistry and collecting as a single fabric on a rotating mandrel What about vascular wall compliance?

Project Aims Synthesize and characterize bioactive PLA scaffolds containing graded layers of variable mechanical compliance, mimicking the compliance of normal and diseased vessels. (Frey) Investigate endothelial cell and vascular smooth muscle cell adhesion, migration, and proliferation within the stratified layers of the matrices in Aim 1, relating the cell behavior to matrix mechanics. (Reinhart-King) Adapt the scaffold in Aim 1 to support an endothelial and vascular smooth muscle cell co-culture in different pressure environments to investigate the effect of endothelial cells on vascular smooth muscle cell behavior. (Vouyouka and Reinhart-King)

Future aims Incorporate to the in vitro vasculature model stents? try to “treat” the “pathologic” in vitro model with the incorporation -NO bubbles or donors - endothelin receptor antagonists - Hyper cooling of the model - ?????

C-myc levels in SMC cultures c-myc actin P<0.03 Vouyouka et al JSR 2003

3D Structured PLA Scaffolds Structured mechanical compliance 3-D architecture Controlled ECM Chemistry Tissue Engineering Tissue Replacement Disease Models for Prevention Schematic of our approach to integrate princples of tissue engineering to create a scaffold for models of atherosclerosis and disease. Shaded areas identify novel areas addressed in our project.